Mark S. Gelder MD - 07 Feb 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Mark Guerin, Attorney-in-Fact
Issuer symbol: TRAW
Transactions as of: 07 Feb 2023
Net transactions value: -$1,689
Form type: 4
Filing time: 08 Feb 2023, 16:58:04 UTC
Previous filing: 04 Aug 2022
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+5,833	+99%		11,729	07 Feb 2023	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$1,689	-1,242	-11%	$1.36	10,487	07 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-5,833	-33%	$0.000000	11,667	07 Feb 2023	Common Stock	5,833		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.